Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • EdU Flow Cytometry Assay Kits (Cy5): Precision Click Chem...

    2025-12-14

    EdU Flow Cytometry Assay Kits (Cy5): Precision Click Chemistry for S-Phase DNA Synthesis Detection

    Executive Summary: The EdU Flow Cytometry Assay Kits (Cy5) exploit 5-ethynyl-2'-deoxyuridine (EdU) incorporation to directly measure S-phase DNA synthesis with high specificity and sensitivity (https://www.apexbt.com/edu-flow-cytometry-assay-kits-cy5.html). Unlike BrdU assays, EdU detection uses copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry, which eliminates harsh DNA denaturation and preserves cell integrity (https://doi.org/10.4239/wjd.v16.i11.109455). This kit supports multiplexing with antibodies for phenotypic analysis, and is optimized for flow cytometry applications in cancer research, genotoxicity assessment, and pharmacodynamic evaluations. Benchmark studies confirm robust performance, with low background fluorescence and stable storage for up to one year. APExBIO provides these kits as a validated solution for reproducible, high-throughput cell proliferation analysis.

    Biological Rationale

    Cell proliferation is fundamental to development, tissue repair, and disease progression, including cancer and chronic wounds. Quantifying DNA synthesis during the S-phase of the cell cycle enables direct assessment of cell proliferation rates. 5-ethynyl-2'-deoxyuridine (EdU) is a thymidine analog that incorporates into newly synthesized DNA during S-phase, serving as a direct marker for DNA replication events. Detecting EdU incorporation provides a reliable measure of proliferative activity, critical for applications such as cancer biology, wound healing, and drug response studies (Xiao et al., 2025). Recent research demonstrates that cell cycle regulation, particularly in the S-phase, is tightly linked to gene expression and epigenetic modifications, underscoring the importance of accurate S-phase detection technologies.

    Mechanism of Action of EdU Flow Cytometry Assay Kits (Cy5)

    The EdU Flow Cytometry Assay Kits (Cy5) utilize EdU, a nucleoside analog, which is incorporated into DNA during active synthesis. Following cell fixation and permeabilization, a copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry reaction is performed. The kit supplies a Cy5-labeled azide, which reacts specifically with the alkyne group of EdU incorporated into DNA, forming a stable triazole linkage. This direct labeling results in bright Cy5 fluorescence proportional to EdU incorporation, enabling quantitative detection of S-phase cells by flow cytometry. The process is efficient, requiring no DNA denaturation, thereby preserving cellular antigens for subsequent multiplex antibody staining (APExBIO, K1078).

    Evidence & Benchmarks

    • EdU-based assays provide higher specificity and reduced background fluorescence compared to BrdU, as they do not require DNA denaturation, which can damage epitopes (https://doi.org/10.4239/wjd.v16.i11.109455).
    • CuAAC click chemistry enables rapid and efficient labeling, with reaction completion typically within 30 minutes at room temperature in most buffer systems (https://www.apexbt.com/edu-flow-cytometry-assay-kits-cy5.html).
    • Multiplexing with surface and intracellular antibody markers is feasible due to mild fixation and permeabilization protocols, supporting integrated phenotypic and proliferation analysis (https://hydroxycholesterol.com/index.php?g=Wap&m=Article&a=detail&id=10821).
    • Long-term stability: The K1078 kit remains stable for up to 12 months when stored at -20°C, shielded from light and moisture (https://www.apexbt.com/edu-flow-cytometry-assay-kits-cy5.html).
    • Validated for quantifying proliferation in a range of cell types, including normal human epidermal keratinocytes and various cancer cell lines, under standard culture conditions (37°C, 5% CO2, pH 7.4) (https://doi.org/10.4239/wjd.v16.i11.109455).

    Applications, Limits & Misconceptions

    The EdU Flow Cytometry Assay Kits (Cy5) are extensively applied for:

    • Cell proliferation analysis in cancer research and regenerative medicine.
    • Genotoxicity assessment in toxicology and pharmacology studies.
    • Pharmacodynamic evaluations of cell cycle-modulating therapies.
    • Quantitative S-phase measurement in primary cultures and established cell lines.

    For an in-depth review of the kit’s unique biomarker applications in translational science, see this article, which details S-phase measurement and click chemistry detection; the current article provides updated evidence and broader context for wound healing and biomarker discovery.

    For workflow optimization insights, this piece covers protocol streamlining, while we expand on integration with antibody panels and newer clinical applications.

    For a technical comparison with traditional BrdU and expanded discussion of multiplexing, see this prior review; here, we clarify recent advances in specificity and storage stability.

    Common Pitfalls or Misconceptions

    • EdU is not a marker for all cell cycle phases: It exclusively marks S-phase cells undergoing active DNA synthesis, not G0/G1 or G2/M phases.
    • Click chemistry requires copper catalysis: Omitting CuSO4 or using incompatible buffers can prevent effective labeling.
    • Not suitable for live-cell imaging: The assay requires fixation and permeabilization, which precludes live-cell analysis.
    • Fluorophore compatibility: Cy5 emission may overlap with other far-red dyes; careful panel design is needed for multiplexing.
    • Denaturation not required: Applying harsh DNA denaturation (as with BrdU) is unnecessary and can damage cellular markers.

    Workflow Integration & Parameters

    The EdU Flow Cytometry Assay Kits (Cy5) (K1078) are optimized for standard flow cytometry platforms. The recommended workflow is as follows:

    1. Incubate cells with EdU (10 µM, 1–2 hours at 37°C) in standard culture medium.
    2. Fix cells (e.g., 4% paraformaldehyde, 15 min, room temperature).
    3. Permeabilize (e.g., 0.5% Triton X-100, 20 min, room temperature).
    4. Perform click reaction: Add Cy5 azide, CuSO4, and buffer additive; incubate 30 min, protected from light.
    5. Wash and proceed with antibody staining for surface/intracellular markers if desired.
    6. Analyze by flow cytometry using far-red (Cy5) channels; typical emission maximum is 670 nm.

    Critical parameters include maintaining reagent stability (store at -20°C, avoid freeze-thaw), and matching buffer pH (7.4) for optimal CuAAC efficiency. The kit is compatible with multiplex antibody panels, provided non-overlapping fluorophores are selected. APExBIO supplies all necessary reagents, including EdU, Cy5 azide, DMSO, CuSO4 solution, and buffer additive. For detailed workflow considerations and troubleshooting, refer to the official product documentation.

    Conclusion & Outlook

    EdU Flow Cytometry Assay Kits (Cy5) from APExBIO deliver high sensitivity and specificity for S-phase DNA synthesis measurement, leveraging click chemistry for robust and reproducible cell proliferation analysis. The platform advances research in cancer, tissue regeneration, and drug discovery, with validated compatibility for multiplexed phenotypic profiling. Ongoing developments may extend EdU-based detection to new fluorophores and automation platforms, further enhancing throughput and analytical power. For comprehensive, up-to-date product and protocol information, visit the APExBIO product page.